CASE Op-Ed in Townhall: Live Nation Led the Anti-Trump Resistance, Now They Want Trump to Save Them
Among the more bizarre yet thoroughly amusing moments from the 2024 campaign was the video footage of President Biden...
CASE Op-Ed in The Hill: It’s Time Congress Break Up Lina Khan’s Monopoly Over Antitrust Reform
March 30, 2023 https://bit.ly/40MyzfR For someone seemingly devoted to the creed “big is bad,” Federal Trade Commission (FTC) Chair Lina...
CASE Op-Ed – Law360: Is Music Industry Consolidation The Next Big Antitrust Fight?
https://bit.ly/3xAYVpP by Gerard Scimeca, CASE Chairman April 18, 2022 The music industry has recently come under significant antitrust scrutiny....
CASE Op-Ed – Washington Times: When Fierce Telecom Rivals Get Close
Gerard Scimeca – Chairman, CASE August 5, 2019 Healthy free-market competition is a major engine of our consumer economy,...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/